MarketPulse

clinical data

6 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Zymeworks to Showcase Pipeline Progress at Major Healthcare Conferences

Zymeworks will present clinical and preclinical data at two major healthcare investor conferences in April, including the Needham Virtual Healthcare Conference and Bloom Burton & Co. event.
ZYMEclinical datainvestor conference
The Motley FoolThe Motley Fool··Eric Volkman

JPMorgan Lifts Edgewise Therapeutics on Pipeline Optimism, Stock Surges

JPMorgan raises Edgewise Therapeutics price target to $45, citing positive long-term clinical data for EDG-7500 and sevasemten. Stock rises 2.18%.
AMJBJPMJPMpCJPMpDJPMpJ+5clinical databiotech
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Corcept Faces Securities Lawsuit Over Relacorilant Claims as FDA Rejection Triggers 50% Stock Decline

Corcept faces securities lawsuit over misleading relacorilant claims. FDA rejected the drug, triggering 50% stock decline and $3.6B market cap loss.
CORTsecurities class actionFDA rejection
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Aquestive to Disclose Q4 2025 Results and Pipeline Progress on March 4-5

Aquestive Therapeutics will report Q4 2025 results March 4 and hold investor call March 5, discussing financial performance and pipeline progress including Anaphylm™ development.
AQSTclinical dataearnings report
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Aquestive to Unveil Anaphylm Clinical Results at 2026 Allergy Conference

Aquestive to present clinical trial data for Anaphylm, an investigational oral anaphylaxis treatment, at 2026 allergy conference, showing promising safety and efficacy results.
AQSTclinical dataFDA approval
BenzingaBenzinga··Vandana Singh

Merck Partners With Mayo Clinic on AI-Driven Drug Discovery Initiative

Merck partners with Mayo Clinic to use AI and advanced analytics for drug discovery, focusing on inflammatory bowel disease, atopic dermatitis, and multiple sclerosis treatment development.
MRKclinical datastrategic partnership